Mr. Chair, I'll respond.
Health Canada has approved 25 rapid tests and, in addition, 10 self-tests. This is comparable to other countries. In fact, it exceeds a number of our key comparator countries. These cover a range of antigen tests and some molecular rapid tests. As has been described, we're working with Public Services and Procurement to procure and deliver 140 million to provinces and territories this month.
In regard to utilization, provinces and territories are using rapid tests as well as PCR tests to support key areas of both diagnosis and critical functions, including in the health system, long-term care, schools and essential services. Dr. Tam can speak further, if you wish, to use guidance prepared by the Public Health Agency, with experts, in terms of enabling both test diagnosis and utilization of Paxlovid.